Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
1.780
-0.090 (-4.81%)
At close: Oct 2, 2026, 4:00 PM EDT
1.820
+0.040 (2.25%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Cellectar Biosciences Market Cap
Cellectar Biosciences has a market cap or net worth of $16.82 million as of October 2, 2026. Its market cap has decreased by -8.56% in one year.
Market Cap
16.82M
Enterprise Value
-15.64M
1-Year Change
-8.56%
Ranking
Category
Stock Price
$1.78
ChartMarket Cap Chart
Since August 15, 2014, Cellectar Biosciences's market cap has increased from $9.20M to $16.82M, an increase of 82.88%. That is a compound annual growth rate of 5.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 16.82M | 34.60% |
| Dec 31, 2025 | 12.50M | 1.63% |
| Dec 31, 2024 | 12.30M | -63.82% |
| Dec 29, 2023 | 34.00M | 112.50% |
| Dec 30, 2022 | 16.00M | -60.59% |
| Dec 31, 2021 | 40.60M | -27.24% |
| Dec 31, 2020 | 55.80M | 164.45% |
| Dec 31, 2019 | 21.10M | 185.14% |
| Dec 31, 2018 | 7.40M | -65.90% |
| Dec 29, 2017 | 21.70M | 233.85% |
| Dec 30, 2016 | 6.50M | 3.17% |
| Dec 31, 2015 | 6.30M | -73.08% |
| Dec 31, 2014 | 23.40M | 154.35% |
| Aug 15, 2014 | 9.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Akari Therapeutics, | 18.92M |
| Marker Therapeutics | 18.34M |
| Lipocine | 17.81M |
| NewcelX | 17.16M |
| Tvardi Therapeutics | 17.07M |
| Palatin Technologies | 17.06M |
| Dyadic International | 16.98M |
| Kiora Pharmaceuticals | 16.54M |